martes, 2 de febrero de 2016

National Guideline Clearinghouse | Guidelines by Topic: Cardiovascular Diseases (4)

National Guideline Clearinghouse | Guidelines by Topic

National Guideline Clearinghouse (NGC)

Guidelines by Topic

Cardiovascular Diseases (393)
61-80 of 393   < Previous Next >
 
61. 
62. 
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome. 2015 Mar. NGC:010694
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
65. 
66. 
Occupational therapy practice guidelines for adults with stroke. 2008 (revised 2015). NGC:010784
American Occupational Therapy Association, Inc. - Professional Association. View all guidelines by the developer(s)
67. 
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. 2014 Dec. NGC:010622
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
68. 
Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block (part review of technology appraisal guidance 88). 2005 Feb (revised 2014 Nov). NGC:010616
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
69. 
Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 2: management of posthemorrhagic hydrocephalus in premature infants. 2014 Nov. NGC:010751
American Association of Neurological Surgeons - Medical Specialty Society; Congress of Neurological Surgeons - Professional Association. View all guidelines by the developer(s)
70. 
Acute heart failure: diagnosing and managing acute heart failure in adults. 2014 Oct. NGC:010568
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
72. 
VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting. 1999 May (revised 2014 Oct). NGC:010598
Department of Defense - Federal Government Agency [U.S.]; Department of Veterans Affairs - Federal Government Agency [U.S.]; Veterans Health Administration - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s)
73. 
Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2014 Sep 2). NGC:010521
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
74. 
75. 
Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.1996 (revised 2014 Aug 19). NGC:010510
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
76. 
Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. 2014 Aug. NGC:010764
American Venous Forum - Disease Specific Society; Society for Vascular Surgery - Medical Specialty Society. View all guidelines by the developer(s)
77. 
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (review of technology appraisal guidance 182). 2009 Oct (revised 2014 Jul). NGC:010499
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
78. 
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 1998 Nov 1 (revised 2014 June 10). NGC:010432
American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Professional Association. View all guidelines by the developer(s)
79. 
Atrial fibrillation: the management of atrial fibrillation. 2006 (revised 2014 Jun). NGC:010473
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
80. 
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120). 2000 Sep (revised 2014 Jun). NGC:010475
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
61-80 of 393   < Previous Next >

No hay comentarios:

Publicar un comentario